Tüm alıştırma soruları

Soru 41Soru →

A university hospital conducts a randomized controlled trial to evaluate the efficacy of a new oral anticoagulant compared to standard therapy for the prevention of deep vein thrombosis (DVT) following total knee arthroplasty. The trial enrolls 1,200 patients, who are randomly assigned in a 1:1 ratio to either the new oral anticoagulant or standard therapy. The results over a 90-day postoperative follow-up period are presented in the table below:

Group	Total Patients	Patients with DVT
New Oral Anticoagulant	600	12
Standard Therapy	600	36

Based on these data, how many patients need to be treated with the new oral anticoagulant instead of standard therapy to prevent one additional case of DVT?

Cevabı ve açıklamayı göster

Cevap: 25

Cevap

25

The Number Needed to Treat (NNT) is an epidemiological measure that indicates how many patients must receive a particular treatment to prevent one additional adverse event. It is calculated as the inverse of the Absolute Risk Reduction (ARR). In this study, the ARR is the difference in deep vein thrombosis incidence between the standard therapy group (

36 / 600 = 0.06

) and the new oral anticoagulant group (

12 / 600 = 0.02

). Therefore,

ARR = 0.06 - 0.02 = 0.04

. The NNT is

1 / 0.04 = 25

. This means 25 patients must be treated with the new anticoagulant instead of standard therapy to prevent one DVT.

Adım Adım Çözüm

1

Calculate the Control Event Rate (CER)

CER = 36 / 600 = 0.06

To find the baseline risk of the outcome (DVT) in patients receiving the standard therapy.

2

Calculate the Experimental Event Rate (EER)

EER = 12 / 600 = 0.02

To find the risk of the outcome (DVT) in patients receiving the new intervention.

3

Calculate the Absolute Risk Reduction (ARR)

ARR = 0.06 - 0.02 = 0.04

To determine the absolute difference in risk between the standard therapy and the new intervention.

4

Calculate the Number Needed to Treat (NNT)

NNT = 1 / 0.04 = 25

To determine how many patients need the new intervention instead of standard therapy to prevent one additional negative outcome.

Anahtar Kavram

Number Needed to Treat (NNT)

Soru 42Soru →

A tropical medicine clinic is evaluating symptomatic patients for a localized outbreak of a novel parasitic infection. The prevalence of the infection among symptomatic patients presenting to this clinic is $20\%$ .

Two independent rapid diagnostic point-of-care tests have been developed to detect the pathogen. They utilize entirely different biological mechanisms: Test A detects a surface glycoprotein antigen, while Test B detects a unique metabolic byproduct. Because they do not cross-react, their performance characteristics are statistically independent for both infected and uninfected individuals.

The performance characteristics of the two tests are as follows:
* Test A: Sensitivity = $80\%$ , Specificity = $90\%$
* Test B: Sensitivity = $90\%$ , Specificity = $80\%$

A patient presents with symptoms and is tested using BOTH assays simultaneously. Both Test A and Test B return a POSITIVE result.

Based on these results, what is the probability (expressed as a percentage) that the patient actually has the infection?

Cevabı ve açıklamayı göster

Cevap: 90

Cevap

90

The positive predictive value (PPV) of a combined independent testing strategy requires finding the joint probability of two true positive results and comparing it against the total probability of two positive results (true positives plus false positives). Using the given prevalence of

20\%

, a hypothetical cohort of

1,000

patients yields

200

diseased and

800

healthy individuals. The joint sensitivity (probability of both tests catching the disease) is

0.80 \times 0.90 = 0.72

, resulting in

144

true positives. The joint false positive rate (probability of both tests failing on a healthy person) is

(1 - 0.90) \times (1 - 0.80) = 0.02

, resulting in

16

false positives. The resulting PPV is

144 / (144 + 16) = 90\%

. Alternatively, this can be calculated by multiplying the pre-test odds (

0.20 / 0.80 = 0.25

) by the combined positive likelihood ratio (

0.72 / 0.02 = 36

) to yield post-test odds of

9.0

, which converts to a

90\%

probability.

Adım Adım Çözüm

1

Calculate the joint sensitivity for the combined testing strategy.

0.80 \times 0.90 = 0.72

(or

72\%

)

Because the tests are biologically and statistically independent, the probability of a diseased patient testing positive on BOTH tests is the product of their individual sensitivities.

2

Calculate the joint false positive rate (FPR) for the combined testing strategy.

Test A FPR =

1 - 0.90 = 0.10

. Test B FPR =

1 - 0.80 = 0.20

. Joint FPR =

0.10 \times 0.20 = 0.02

(or

2\%

).

To find the probability of a healthy patient falsely testing positive on BOTH independent tests, you must multiply their individual false positive rates (which is

1 - \text{Specificity}

).

3

Determine the number of true positives and false positives in a hypothetical population of 1,000 patients.

Disease Present (

20\%

):

200

patients. Disease Absent (

80\%

):

800

patients. True Positives:

200 \times 0.72 = 144

. False Positives:

800 \times 0.02 = 16

.

Mapping the probabilities to a theoretical population makes the Positive Predictive Value (PPV) calculation straightforward using a standard

2 \times 2

contingency framework.

4

Calculate the Positive Predictive Value (PPV).

PPV = \frac{144}{144 + 16} = \frac{144}{160} = 0.90

.

PPV represents the probability that the patient has the disease given the specific positive test results. It is the ratio of true positives to total positives.

Anahtar Kavram

Calculating the Positive Predictive Value (PPV) of a dual independent testing strategy using joint probabilities.

Soru 43Soru →

A local public health department evaluates a community-based dietary intervention aimed at reducing fasting blood glucose levels in patients with prediabetes. A preliminary study of $36$ participants reveals a mean fasting blood glucose reduction of $18.0$ mg/dL after 6 months. The reported 95% confidence interval for this mean reduction is $12.0$ to $24.0$ mg/dL.

Based on these promising results, the investigators are planning a larger follow-up study using an identical intervention in the same population. They assume the population variance will remain exactly the same and that the standard normal distribution (z-score) will be used to construct the confidence intervals in both analyses.

If the follow-up study successfully enrolls and analyzes $144$ participants, what will be the total width of the 95% confidence interval for the mean reduction in fasting blood glucose in the new study?

Cevabı ve açıklamayı göster

Cevap: 6

Cevap

6.0

The total width of a confidence interval is defined by the formula:

Width = 2 \times z \times \frac{\sigma}{\sqrt{n}}

. When the population standard deviation (

\sigma

) and the critical value (

z

) are held constant, the width of the confidence interval relies solely on the sample size (

n

). Because

n

is in the denominator under a square root, the width is inversely proportional to

\sqrt{n}

. In this scenario, the initial sample size is

36

, resulting in a width of

24.0 - 12.0 = 12.0

mg/dL. The new sample size is

144

. The ratio of the new sample size to the old sample size is

\frac{144}{36} = 4

. Therefore, the new standard error will be divided by

\sqrt{4} = 2

. Consequently, the original total width (

12.0

mg/dL) is halved, resulting in a new total width of

6.0

mg/dL.

Adım Adım Çözüm

1

Calculate the width of the original confidence interval.

The width is

24.0 - 12.0 = 12.0

mg/dL.

The total width of a confidence interval represents twice the margin of error.

2

Identify the relationship between sample size (

n

) and confidence interval width.

Width

\propto \frac{1}{\sqrt{n}}

.

The width of a confidence interval is calculated as

2 \times z \times \frac{\sigma}{\sqrt{n}}

. Assuming

z

and

\sigma

are constant, the width is inversely proportional to the square root of the sample size.

3

Determine the scale factor for the sample size increase.

\frac{144}{36} = 4

. The sample size is multiplied by

4

.

Comparing the new sample size (

144

) to the original sample size (

36

) provides the proportional increase.

4

Calculate the new confidence interval width.

\frac{12.0}{\sqrt{4}} = \frac{12.0}{2} = 6.0

mg/dL.

Because the sample size increased by a factor of

4

, the standard error (and therefore the confidence interval width) decreases by a factor of

\sqrt{4}

, which is

2

.

Anahtar Kavram

The width of a confidence interval is inversely proportional to the square root of the sample size. Increasing the sample size by a factor of

X

reduces the confidence interval width by a factor of

\sqrt{X}

.

Soru 44Soru →

An infectious disease ward at a metropolitan hospital frequently evaluates patients presenting with presumed bacterial meningitis. During the winter season, epidemiological records indicate that $20\%$ of these admitted patients are ultimately confirmed to have a bacterial etiology via standard cerebrospinal fluid (CSF) culture. To expedite initial patient management, the hospital introduces a rapid CSF polymerase chain reaction (PCR) panel. Clinical validation of this rapid PCR panel demonstrates a sensitivity of $80\%$ and a specificity of $95\%$ . If this rapid PCR panel is applied to a representative cohort of $1,000$ such admissions, what is the expected positive predictive value (expressed as a percentage) of a positive test result?

Cevabı ve açıklamayı göster

Cevap: 80

Cevap

80

To find the positive predictive value (PPV), we must determine the proportion of positive test results that are true positives. In a theoretical population of

1,000

patients with a

20\%

prevalence,

200

patients actually have bacterial meningitis and

800

do not. Using the test's sensitivity of

80\%

, there are

160

true positives (

200 \times 0.80

). Using the specificity of

95\%

, the false positive rate is

5\%

, yielding

40

false positives (

800 \times 0.05

). The total number of positive test results is

200

(

160 \text{ TP} + 40 \text{ FP}

). The PPV is the ratio of true positives to total positive tests:

\frac{160}{200} = 0.80

, which equates to

80\%

.

Adım Adım Çözüm

1

Calculate the actual number of diseased and non-diseased individuals in the cohort.

Disease Present =

200

; Disease Absent =

800

The prevalence is

20\%

. In a cohort of

1,000

patients,

1,000 \times 0.20 = 200

have the disease, leaving

800

without the disease.

2

Calculate the number of True Positives (TP).

TP =

160

Sensitivity is the proportion of diseased individuals who test positive.

200 \times 0.80 = 160

.

3

Calculate the number of False Positives (FP).

FP =

40

False positives arise from the non-diseased group. Since specificity is

95\%

, the false positive rate is

5\%

.

800 \times 0.05 = 40

.

4

Calculate the Positive Predictive Value (PPV).

PPV =

80\%

PPV is the number of True Positives divided by the total number of positive tests.

\frac{160}{160 + 40} = \frac{160}{200} = 0.80

, which is

80\%

.

Anahtar Kavram

Positive Predictive Value (PPV) depends heavily on the prevalence of the disease in the tested population, in addition to the test's sensitivity and specificity.

Soru 45Soru →

A regional occupational health board is evaluating the impact of night-shift work on metabolic health among healthcare workers. Demographic data indicate that $40\%$ of the nursing workforce in this region is assigned to permanent night shifts. A comprehensive longitudinal study demonstrates that the relative risk of developing type 2 diabetes mellitus over a 10-year period for night-shift nurses, compared to their day-shift counterparts, is $2.5$ . Assuming the association is causal, what percentage of the incident type 2 diabetes cases in this entire nursing population can be attributed to night-shift work? (Enter your answer as a percentage.)

Cevabı ve açıklamayı göster

Cevap: 37.5

Cevap

37.5

The Population Attributable Risk Percent (PAR%) represents the proportion of disease incidence in a total population that can be attributed to a specific exposure. When raw incidence rates are not available, PAR% can be calculated using Levin's formula:

PAR\% = \frac{P_e(RR - 1)}{P_e(RR - 1) + 1} \times 100

, where

P_e

is the prevalence of the exposure and

RR

is the relative risk. Substituting the given values (

P_e = 0.40

,

RR = 2.5

) yields

\frac{0.40(1.5)}{0.40(1.5) + 1} = \frac{0.60}{1.60} = 0.375

, or

37.5\%

.

Adım Adım Çözüm

1

Identify variables from the stem

Prevalence of exposure (

P_e

) =

0.40

; Relative risk (

RR

) =

2.5

.

These are the two required variables to calculate the population attributable risk percent when raw incidence rates are not provided.

2

Select the appropriate epidemiological formula

PAR\% = \frac{P_e(RR - 1)}{P_e(RR - 1) + 1} \times 100

Levin's formula allows calculation of the proportion of disease in the total population attributable to an exposure using only prevalence and relative risk.

3

Calculate the attributable fraction

Numerator:

0.40 \times 1.5 = 0.60

. Denominator:

0.60 + 1 = 1.60

. Fraction:

\frac{0.60}{1.60} = 0.375

.

Performing the algebraic substitution determines the decimal value of the attributable risk.

4

Convert to percentage

37.5\%

The question specifically asks for the percentage of incident cases.

Anahtar Kavram

Population Attributable Risk Percent (PAR%) using Levin's Formula

Soru 46Soru →

A team of dermatological researchers is investigating a novel topical gene therapy for severe atopic dermatitis in a randomized, double-blind, vehicle-controlled clinical trial. The study is appropriately powered at $80\%$ ( $\beta = 0.20$ ) to evaluate the primary endpoint, which is the mean change in the Eczema Area and Severity Index (EASI) score at 12 weeks.

During the design phase, the investigators pre-specify the analysis of $20$ distinct and independent secondary outcomes, including various serological cytokine levels, epidermal barrier function metrics, and sleep disruption indices. The researchers aim to maintain the overall study-wide probability of committing a Type I error at exactly $5\%$ ( $\alpha = 0.05$ ) across the analysis of these secondary outcomes. To counteract the problem of multiple comparisons, the biostatistician applies a Bonferroni correction to adjust the significance level.

Based on this statistical design, what specific $p$ -value threshold must a single secondary outcome achieve to be considered statistically significant? (Express the answer as a precise decimal).

Cevabı ve açıklamayı göster

Cevap: 0.0025

Cevap

The correct adjusted threshold is 0.0025.

The Bonferroni correction is a conservative statistical method used to counteract the problem of multiple comparisons. When multiple independent hypothesis tests are performed simultaneously, the cumulative chance of committing at least one Type I error (a false positive) increases significantly. To maintain a specific family-wise error rate (in this case,

\alpha = 0.05

), the Bonferroni method divides the desired overall

\alpha

by the total number of hypotheses being tested in that group (

n

). For the

20

secondary outcomes in this trial, the adjusted

p

-value threshold is calculated as

0.05 / 20 = 0.0025

. Therefore, any single secondary endpoint must yield a

p

-value less than

0.0025

to be considered statistically significant.

Adım Adım Çözüm

1

Identify the desired overall Type I error rate (

\alpha

).

\alpha = 0.05

The researchers want to cap the study-wide probability of a false positive among the secondary outcomes at

5\%

.

2

Identify the number of secondary endpoints being tested (

n

).

n = 20

The Bonferroni correction requires dividing the overall

\alpha

by the number of simultaneous comparisons being made within that family.

3

Calculate the adjusted

p

-value threshold.

0.05 / 20 = 0.0025

Applying the Bonferroni formula (

\alpha_{adjusted} = \alpha / n

) ensures that the cumulative probability of committing at least one Type I error across all tests does not exceed

0.05

.

Anahtar Kavram

Bonferroni Correction for Multiple Comparisons

Soru 47Soru →

A 45-year-old female healthcare worker presents to the occupational health clinic for routine screening. A research consortium is currently analyzing the efficacy of a new serum assay for detecting latent tuberculosis infection at this facility. In a recent validation cohort, the assay was administered to $200$ individuals with confirmed latent tuberculosis and $800$ individuals who are definitively uninfected. The assay yielded a positive result in $170$ of the infected individuals and in $40$ of the uninfected individuals.

Based on these validation study results, what is the positive likelihood ratio of this new serum assay?

Cevabı ve açıklamayı göster

Cevap: 17

Cevap

17

The positive likelihood ratio (LR+) is calculated as Sensitivity divided by (1 - Specificity). In this study, the sensitivity is

170/200

(

0.85

) and the false positive rate (1 - Specificity) is

40/800

(

0.05

). Dividing

0.85

by

0.05

yields an LR+ of

17

. This means a positive test result is 17 times more likely to be seen in someone with latent tuberculosis than in someone without it.

Adım Adım Çözüm

1

Calculate the test's sensitivity.

Sensitivity = TP / Total Diseased = 170 / 200 = 0.85.

Sensitivity is the numerator in the positive likelihood ratio equation.

2

Calculate the false positive rate.

False Positive Rate = FP / Total Healthy = 40 / 800 = 0.05.

The false positive rate (1 - Specificity) is the denominator in the positive likelihood ratio equation.

3

Calculate the positive likelihood ratio.

LR+ = 0.85 / 0.05 = 17.

Dividing the true positive rate by the false positive rate yields the positive likelihood ratio.

Anahtar Kavram

Calculation of Positive Likelihood Ratio (LR+) from raw clinical validation data.

Soru 48Soru →

A prospective study evaluates the diagnostic performance of a rapid point-of-care synovial fluid assay for detecting septic arthritis. The study enrolls $1,000$ adult patients presenting to the emergency department with acute monoarticular joint effusions. All patients undergo both the rapid assay and a gold-standard synovial fluid culture. The culture confirms septic arthritis in $200$ patients. Among these confirmed cases, the rapid assay is positive in $180$ patients. Across the entire study cohort of $1,000$ patients, the rapid assay is positive in a total of $580$ patients. What is the negative likelihood ratio of this rapid assay? (Express your answer as a decimal).

Cevabı ve açıklamayı göster

Cevap: 0.2

Cevap

0.20

To find the negative likelihood ratio (

LR-

), we must calculate the sensitivity and specificity from the study data. The study gives a gold-standard disease-positive population of

200

. Out of these,

180

test positive, making the Sensitivity

180/200 = 0.90

. The remaining

800

patients are disease-negative. Because the total number of positive tests is

580

, the number of false positives (positive test in a disease-negative patient) is

580 - 180 = 400

. The number of true negatives is therefore

800 - 400 = 400

. Specificity is

400 / 800 = 0.50

. The formula for

LR-

is

(1 - \text{Sensitivity}) / \text{Specificity}

. Substituting the values yields

(1 - 0.90) / 0.50 = 0.10 / 0.50 = 0.20

.

Adım Adım Çözüm

1

Determine disease prevalence numbers from the total cohort.

Disease Positive = 200; Disease Negative = 800.

Establishing the absolute numbers for the presence and absence of the disease is required before calculating the true/false positive and negative rates.

2

Calculate the test Sensitivity.

Sensitivity = 180 / 200 = 0.90.

Sensitivity is the proportion of disease-positive individuals who correctly test positive (True Positives / Total Disease Positive).

3

Deduce False Positives (FP) and True Negatives (TN) to calculate Specificity.

FP = 580 - 180 = 400. TN = 800 - 400 = 400. Specificity = 400 / 800 = 0.50.

Because only the total number of positive tests (580) was given, subtracting the true positives (180) isolates the false positives. True negatives are the remainder of the disease-negative group.

4

Calculate the Negative Likelihood Ratio (

LR-

).

LR- = (1 - 0.90) / 0.50 = 0.20

.

The negative likelihood ratio is calculated as the False Negative Rate divided by the True Negative Rate (Specificity), representing the probability of a negative test in a patient with the disease divided by the probability of a negative test in a patient without the disease.

Anahtar Kavram

The negative likelihood ratio (

LR-

) is calculated as

(1 - \text{Sensitivity}) / \text{Specificity}

. It requires extracting the true positive and false positive rates from clinical study totals.

Soru 49Soru →

Physicians at a tertiary care center are evaluating a novel immunoassay for diagnosing acute mesenteric ischemia. To determine the test's clinical utility, they apply it to a cohort of patients presenting with acute abdominal pain.

Among $120$ patients who are ultimately diagnosed with acute mesenteric ischemia via angiography, the immunoassay returns a positive result in $102$ cases. In another group of $400$ patients whose abdominal pain is confirmed to be non-ischemic in origin, the immunoassay is positive in $40$ cases.

Based on these findings, what is the positive likelihood ratio of this novel immunoassay?

Cevabı ve açıklamayı göster

Cevap: 8.5

Cevap

8.5

The positive likelihood ratio (

LR+

) is calculated by dividing a test's sensitivity by its false positive rate (

1 - \text{Specificity}

). The sensitivity is the proportion of true positives among all those with the disease (

102/120 = 0.85

). The false positive rate is the proportion of false positives among all those without the disease (

40/400 = 0.10

). Dividing

0.85

by

0.10

yields

8.5

. This indicates that a positive test result is 8.5 times more likely to be observed in a patient with acute mesenteric ischemia than in a patient without it.

Adım Adım Çözüm

1

Calculate the sensitivity of the assay.

0.85

Sensitivity represents the proportion of patients with the disease who test positive (

102 / 120

).

2

Calculate the false positive rate (

1 - \text{Specificity}

).

0.10

The false positive rate represents the proportion of disease-free patients who incorrectly test positive (

40 / 400

).

3

Calculate the positive likelihood ratio (

LR+

).

8.5

LR+

is the ratio of sensitivity to the false positive rate (

0.85 / 0.10

).

Anahtar Kavram

The positive likelihood ratio (

LR+

) indicates how much more likely a positive test result is to occur in a patient with the disease compared to a patient without the disease, calculated as Sensitivity / (

1 - \text{Specificity}

).

Soru 50Soru →

An infectious disease research group is evaluating a new rapid serological test for identifying acute Zika virus infection in an endemic region. In the initial validation study, $1,000$ symptomatic individuals were tested. Among the $200$ patients with PCR-confirmed Zika virus, the rapid test was positive in $180$ . Among the $800$ patients without Zika virus, the rapid test was positive in $80$ .

The test is subsequently deployed to a different clinic during a localized outbreak, where the prevalence of acute Zika virus among symptomatic patients is $25\%$ . Assuming the test's intrinsic properties remain unchanged, if a symptomatic patient at this new clinic receives a positive result on the rapid test, what is the probability (in percent) that they actually have the infection?

Cevabı ve açıklamayı göster

Cevap: 75

Cevap

75

The probability that a patient with a positive test actually has the disease is the Positive Predictive Value (PPV). Unlike sensitivity and specificity, which are intrinsic properties of the test, PPV changes with the prevalence of the disease in the tested population. First, the intrinsic properties are calculated from the validation study: Sensitivity =

180 / 200 = 90\%

, and Specificity =

(800 - 80) / 800 = 90\%

. When the test is moved to a clinic with a

25\%

prevalence, a theoretical cohort of

1,000

patients would have

250

diseased and

750

healthy individuals. The test would correctly identify

225

of the diseased patients (

250 \times 0.90

) and incorrectly identify

75

of the healthy patients (

750 \times 0.10

). The PPV is the ratio of true positives to total positives:

225 / (225 + 75) = 225 / 300 = 75\%

.

Adım Adım Çözüm

1

Determine the test's sensitivity from the initial validation study.

Sensitivity is

90\%

.

Sensitivity is the proportion of patients with the disease who test positive. Out of

200

patients with Zika virus,

180

tested positive.

\frac{180}{200} = 0.90

.

2

Determine the test's specificity from the initial validation study.

Specificity is

90\%

.

Specificity is the proportion of patients without the disease who test negative. Out of

800

patients without Zika virus,

80

tested positive (false positives). True negatives =

800 - 80 = 720

.

\frac{720}{800} = 0.90

.

3

Calculate the expected number of true positives in the new clinic.

For every

1,000

patients, there are

225

true positives.

The new prevalence is

25\%

, so in a cohort of

1,000

patients,

250

have the disease. True Positives =

250 \times 0.90 = 225

.

4

Calculate the expected number of false positives in the new clinic.

For every

1,000

patients, there are

75

false positives.

In the cohort of

1,000

patients,

750

do not have the disease. The false positive rate is

1 - \text{Specificity} = 1 - 0.90 = 0.10

. False Positives =

750 \times 0.10 = 75

.

5

Calculate the Positive Predictive Value (PPV).

The PPV is

75\%

.

\text{PPV} = \frac{\text{True Positives}}{\text{True Positives} + \text{False Positives}} = \frac{225}{225 + 75} = \frac{225}{300} = 0.75

.

Anahtar Kavram

Positive Predictive Value (PPV) depends heavily on disease prevalence; as prevalence changes, PPV must be recalculated using the test's intrinsic sensitivity and specificity.

Soru 51Soru →

A team of clinical researchers is investigating the efficacy of a new intensive lifestyle modification program on glycemic control in patients with newly diagnosed type 2 diabetes. In a study of $144$ patients, the mean reduction in hemoglobin A1c (HbA1c) after six months is $1.2\%$ . The sample standard deviation for this reduction is $0.6\%$ . Assuming a normal distribution of the data and using a critical z-score of $1.96$ for the $95\%$ confidence level, what is the upper bound of the $95\%$ confidence interval for the mean reduction in HbA1c in this population? (Express your answer to three decimal places.)

Cevabı ve açıklamayı göster

Cevap: 1.298

Cevap

1.298

The

95\%

confidence interval provides a range of values within which the true population mean is expected to fall. It is calculated using the sample mean, the standard error of the mean, and the corresponding z-score. The standard error (SE) is determined by dividing the standard deviation by the square root of the sample size (

SE = 0.6 / \sqrt{144} = 0.05

). The margin of error is the product of the z-score and the SE (

1.96 \times 0.05 = 0.098

). The upper bound is calculated by adding this margin to the sample mean (

1.2 + 0.098 = 1.298

).

Adım Adım Çözüm

1

Calculate the standard error (SE) of the mean.

0.6 / \sqrt{144} = 0.05

SE quantifies the precision of the sample mean estimate and is necessary for constructing the confidence interval.

2

Calculate the margin of error.

1.96 \times 0.05 = 0.098

The margin of error defines the width of the confidence interval on either side of the mean.

3

Calculate the upper bound of the 95% confidence interval.

1.2 + 0.098 = 1.298

The upper bound is found by adding the margin of error to the point estimate (mean).

Anahtar Kavram

The confidence interval for a sample mean is calculated as

Mean \pm (z-score \times Standard Error)

, where Standard Error is the standard deviation divided by the square root of the sample size.

Soru 52Soru →

Physicians at an ambulatory clinic are validating a rapid point-of-care urine antigen test for *Legionella pneumophila*. During a localized outbreak, 800 adult patients with symptoms of community-acquired pneumonia undergo testing with both the rapid antigen test and a reference standard polymerase chain reaction (PCR) assay. The PCR assay detects *Legionella* in 150 patients. The rapid antigen test is positive in 105 of these PCR-positive patients. Additionally, the rapid antigen test is positive in 35 patients who are negative by PCR. What is the positive predictive value of the rapid antigen test in this patient population? (Express your answer as a percentage).

Cevabı ve açıklamayı göster

Cevap: 75

Cevap

75

The positive predictive value (PPV) is the probability that a patient with a positive test result actually has the disease. It is calculated by dividing the number of true positives (TP) by the total number of positive test results (TP + false positives [FP]). In this scenario, the TP is 105 (patients with PCR-confirmed infection who tested positive). The FP is 35 (patients without PCR-confirmed infection who tested positive). Therefore, the PPV is calculated as 105 / (105 + 35) = 105 / 140 = 0.75, which corresponds to 75%.

Adım Adım Çözüm

1

Extract the true positive (TP) and false positive (FP) values from the scenario.

TP = 105; FP = 35.

PPV calculation requires knowing how many patients correctly tested positive versus falsely tested positive.

2

Apply the Positive Predictive Value formula.

PPV = \frac{TP}{TP + FP}

This formula determines the proportion of positive test results that are truly positive.

3

Substitute the values into the formula and solve.

\frac{105}{140} = 0.75

Provides the PPV as a decimal.

4

Convert the decimal to a percentage.

0.75 \times 100 = 75

The question asks for the answer as a percentage.

Anahtar Kavram

Positive Predictive Value (PPV)

Tahmini Süre:1m 0s

Soru 53Soru →

A city health department is evaluating a new rapid antigen test for a circulating strain of influenza. Surveillance data indicates that the prevalence of this influenza strain among symptomatic patients presenting to urgent care clinics is $20\%$ . In this specific clinical setting, validation studies demonstrate that the rapid antigen test has a positive predictive value of $50\%$ and a sensitivity of $80\%$ .

Based on these findings, what is the specificity of this new rapid antigen test? (Enter the value as a percentage)

Cevabı ve açıklamayı göster

Cevap: 80

Cevap

80

Specificity is defined as the proportion of patients without the disease who correctly test negative. By using the provided prevalence (

20\%

) and sensitivity (

80\%

), we determine the true positive rate for a hypothetical cohort. We then use the positive predictive value (

50\%

) formula algebraically to deduce the absolute number of false positives. Subtracting false positives from the total disease-negative population yields the true negatives, allowing us to calculate a final specificity of

80\%

.

Adım Adım Çözüm

1

Set up a hypothetical population to calculate absolute numbers based on the given prevalence.

In a population of 1000 patients with a 20% prevalence, there are 200 patients with influenza and 800 patients without influenza.

Using a hypothetical round number (like 1000) simplifies the translation of probabilities into a standard 2x2 contingency table without dealing with decimals.

2

Calculate the True Positives (TP) using the given sensitivity.

TP = 200 * 0.80 = 160 patients.

Sensitivity is defined as the proportion of actual positive cases that are correctly identified by the test.

3

Use the Positive Predictive Value (PPV) formula to solve for False Positives (FP).

0.50 = 160 / (160 + FP) => 0.50 * (160 + FP) = 160 => 80 + 0.50 * FP = 160 => FP = 160 patients.

PPV is the probability that a positive test result is a true positive. Working backward from PPV allows us to identify how many false positives occurred.

4

Calculate True Negatives (TN) by subtracting False Positives from the total disease-free population.

TN = 800 (Total without disease) - 160 (FP) = 640 patients.

The entire disease-free population must either test positive (False Positives) or negative (True Negatives).

5

Calculate the specificity of the test.

Specificity = 640 / 800 = 0.80 or 80%.

Specificity is defined as the proportion of individuals without the disease who correctly test negative (TN / Total without disease).

Anahtar Kavram

Calculating Specificity using Prevalence, Sensitivity, and Positive Predictive Value

Soru 54Soru →

A research group evaluates a novel high-resolution ultrasound technique for diagnosing giant cell arteritis (GCA) in patients over 50 years of age presenting with new-onset headaches. A prospective study enrolls 1,000 such patients. Each patient undergoes the novel ultrasound followed by a temporal artery biopsy, which serves as the gold standard.

Biopsy results confirm the diagnosis of GCA in 150 patients. The novel ultrasound finding is present in 120 of these biopsy-confirmed cases. Among the patients with a negative biopsy, the ultrasound finding is present in 34 patients.

Based on these study results, what is the positive likelihood ratio ( $LR+$ ) of this novel ultrasound finding for diagnosing giant cell arteritis?

Cevabı ve açıklamayı göster

Cevap: 20

Cevap

20

The positive likelihood ratio is calculated using the formula: LR+ = Sensitivity / (1 - Specificity). First, calculate the sensitivity: 120 True Positives / 150 Total Disease Positives = 0.80. Next, calculate the false positive rate (1 - Specificity): 34 False Positives / 850 Total Disease Negatives = 0.04. Finally, divide the sensitivity by the false positive rate: 0.80 / 0.04 = 20.

Adım Adım Çözüm

1

Determine the number of True Positives (TP) and the total number of patients with the disease.

Total patients with GCA = 150. True Positives (TP) = 120.

These values are required to calculate the sensitivity of the test.

2

Calculate the Sensitivity (True Positive Rate).

Sensitivity = 120 / 150 = 0.80 (80%).

Sensitivity forms the numerator of the positive likelihood ratio.

3

Determine the number of False Positives (FP) and the total number of patients without the disease.

Total patients without GCA = 1000 - 150 = 850. False Positives (FP) = 34.

These values are required to calculate the false positive rate (1 - specificity).

4

Calculate the False Positive Rate (1 - Specificity).

False Positive Rate = FP / Total Disease Negative = 34 / 850 = 0.04 (4%).

The false positive rate forms the denominator of the positive likelihood ratio.

5

Calculate the Positive Likelihood Ratio (LR+).

LR+ = Sensitivity / (1 - Specificity) = 0.80 / 0.04 = 20.

This formula yields the likelihood of a positive test result in a patient with the disease compared to a patient without the disease.

Anahtar Kavram

The positive likelihood ratio (LR+) is calculated as Sensitivity divided by (1 - Specificity). It indicates how much more likely a positive test result is to occur in a patient with the disease compared to a patient without the disease.

Soru 55Soru →

A pharmacovigilance research group is conducting a retrospective analysis of clinical trials investigating various homeopathic remedies for the treatment of seasonal allergic rhinitis. The researchers identify a total of 140 independent, randomized controlled trials that compared a specific homeopathic intervention to a matching placebo. It is firmly established by comprehensive biochemical analysis that this homeopathic remedy contains only water and is biologically completely inert, meaning it has the exact same true clinical effect as the placebo.

Each of the 140 clinical trials was rigorously designed and executed with a pre-specified significance level ( $\alpha$ ) of 0.05 and a statistical power of 80%.

Based on the principles of hypothesis testing, how many of these 140 trials are expected to report a statistically significant difference in efficacy between the homeopathic remedy and the placebo purely by chance?

Cevabı ve açıklamayı göster

Cevap: 7

Cevap

7

The null hypothesis states that there is no true difference between the intervention and the placebo. Because the homeopathic remedy is completely inert and identical to water, the null hypothesis is absolutely true. A Type I error occurs when researchers incorrectly reject a true null hypothesis, concluding that a statistically significant difference exists when none actually does. The probability of making a Type I error is determined entirely by the pre-specified significance level (

\alpha

), which is set to 0.05. Therefore, in 140 independent trials where the intervention has no true clinical effect, we expect 5% of them to report a statistically significant difference purely due to random chance. The calculation is

140 \times 0.05 = 7

. Statistical power (80%) and Type II error (20%) are irrelevant in this scenario because they only apply when the alternative hypothesis is true (i.e., when the drug actually works).

Adım Adım Çözüm

1

Determine the true state of the intervention to identify which statistical errors apply.

The intervention is biologically inert and identical to placebo, meaning the null hypothesis of no difference is true in reality.

To distinguish whether a Type I error (false positive) or Type II error (false negative) is statistically possible in this scenario.

2

Identify the probability of concluding a statistically significant difference when the null hypothesis is true.

This probability is defined by the significance level (

\alpha

), which is given as 0.05 (or 5%).

A Type I error occurs when the null hypothesis is incorrectly rejected due to random sampling variation.

3

Calculate the expected number of trials that will show a statistically significant difference.

140 trials

\times 0.05 = 7

expected trials.

The expected frequency of an event is the probability of the event multiplied by the total number of independent trials.

Anahtar Kavram

Type I Error (

\alpha

) Expected Frequency

Soru 56Soru →

A rural community health center introduces a new rapid point-of-care test for Lyme disease during the summer months. Based on epidemiological data, the pre-test probability of a patient having Lyme disease when presenting with non-specific flu-like symptoms in this region is $25\%$ . The rapid test has a documented sensitivity of $84\%$ and a specificity of $92\%$ . A 32-year-old forestry worker presents with malaise and myalgia and tests positive on this new assay. What is the positive predictive value of this test for this patient? Express your answer as a percentage rounded to one decimal place.

Cevabı ve açıklamayı göster

Cevap: 77.8

Cevap

77.8

The positive predictive value (PPV) is the probability that a patient with a positive test result actually has the disease. It is calculated by dividing the true positive results by the total positive results (true positives + false positives). Using the given prevalence of

25\%

, sensitivity of

84\%

, and specificity of

92\%

, a hypothetical population of 10,000 yields 2,100 true positives and 600 false positives, resulting in a PPV of

\frac{2,100}{2,700} \approx 77.8\%

.

Adım Adım Çözüm

1

Identify the given statistical parameters for the clinical scenario.

Prevalence =

25\%

(

0.25

), Sensitivity =

84\%

(

0.84

), Specificity =

92\%

(

0.92

).

These are the necessary components to calculate predictive values.

2

Set up a hypothetical population to calculate exact patient numbers.

Assume a population of

10,000

patients.

Using whole numbers makes calculating true positives and false positives more intuitive than calculating compound probabilities.

3

Calculate the number of patients who actually have the disease (Disease Positive) and those who do not (Disease Negative).

Disease Positive =

10,000 \times 0.25 = 2,500

. Disease Negative =

10,000 - 2,500 = 7,500

.

Prevalence dictates the baseline disease status in the population.

4

Calculate True Positives (TP) and False Positives (FP).

TP =

2,500 \times 0.84 = 2,100

. FP =

7,500 \times (1 - 0.92) = 7,500 \times 0.08 = 600

.

TP is derived from sensitivity applied to diseased patients. FP is derived from the false positive rate (

1 - \text{Specificity}

) applied to healthy patients.

5

Calculate the Positive Predictive Value (PPV).

PPV =

\frac{\text{TP}}{\text{TP} + \text{FP}} = \frac{2,100}{2,100 + 600} = \frac{2,100}{2,700} \approx 0.7777

or

77.8\%

.

PPV represents the proportion of all positive test results that are true positives.

Anahtar Kavram

Positive Predictive Value (PPV) Calculation and Dependence on Prevalence

Soru 57Soru →

An international health consortium is assessing a novel rapid antigen test for detecting a newly identified strain of avian influenza in symptomatic individuals. During the initial clinical validation phase, the test was administered to $2,000$ patients with respiratory symptoms. Confirmatory polymerase chain reaction (PCR) testing, acting as the gold standard, diagnosed the influenza strain in $400$ of these patients. The novel rapid test returned a positive result in $360$ of the infected patients. Among the patients confirmed to be uninfected by PCR, the rapid test incorrectly indicated a positive result in $240$ individuals.

Based on these performance metrics, the consortium decides to implement the rapid test at a dedicated respiratory triage center where historical epidemiological data indicates the prevalence of this specific influenza strain is $30\%$ among presenting patients.

Assuming the intrinsic diagnostic properties of the test remain constant, what is the positive predictive value of the rapid antigen test in this triage center? (Express your answer as a percentage)

Cevabı ve açıklamayı göster

Cevap: 72

Cevap

72

The correct calculation accounts for the shift in prevalence while maintaining the intrinsic test properties. From the validation study, Sensitivity is 90% (

360/400

) and Specificity is 85% (

1360/1600

). In a new population with

30\%

prevalence, a cohort of

1,000

patients yields

300

diseased and

700

non-diseased individuals. The test will accurately identify

270

of the diseased patients (True Positives =

300 \times 0.90

) and inaccurately identify

105

of the non-diseased patients as positive (False Positives =

700 \times 0.15

). The Positive Predictive Value is the ratio of True Positives to all positives:

270 / (270 + 105) = 270 / 375 = 0.72

, or

72\%

.

Adım Adım Çözüm

1

Calculate the test's sensitivity and specificity from the initial validation cohort.

Sensitivity = 90%, Specificity = 85%

Sensitivity and specificity are intrinsic properties of the test and remain constant regardless of disease prevalence. Sensitivity = TP / Total Disease Positive = 360 / 400 = 0.90. Specificity = TN / Total Disease Negative = (1600 - 240) / 1600 = 1360 / 1600 = 0.85.

2

Establish the disease distribution in the new triage center population.

Disease positive = 30%, Disease negative = 70%

The new clinical setting has a known prevalence of 30%, which acts as the pre-test probability.

3

Calculate the expected number of True Positives (TP) and False Positives (FP) for a hypothetical cohort of 1,000 patients in the triage center.

TP = 270, FP = 105

TP is calculated as (Prevalence) * (Sensitivity) * 1000 = 300 * 0.90 = 270. FP is calculated as (1 - Prevalence) * (1 - Specificity) * 1000 = 700 * 0.15 = 105.

4

Calculate the Positive Predictive Value (PPV) using the new TP and FP values.

PPV = 72%

PPV represents the probability that a positive test result is a true positive. PPV = TP / (TP + FP) = 270 / (270 + 105) = 270 / 375 = 0.72, or 72%.

Anahtar Kavram

While sensitivity and specificity are intrinsic to a diagnostic test and do not change with disease prevalence, predictive values (PPV and NPV) are highly dependent on the prevalence of the disease in the tested population.

Soru 58Soru →

A team of epidemiologists is investigating a potential association between the regular consumption of a novel energy drink and the incidence of new-onset atrial fibrillation in young adults. A cross-sectional survey is administered to a random sample of $1,000$ university students. The survey reveals that $200$ students consume the energy drink regularly. Additionally, clinical records indicate that $50$ students in the total sample have experienced at least one episode of atrial fibrillation.

To determine if there is a statistically significant association between energy drink consumption and atrial fibrillation, the researchers plan to use a Chi-square test of independence. Assuming the null hypothesis is true, what is the expected number of students who both consume the energy drink regularly and have experienced atrial fibrillation? (Enter your answer as a whole number).

Cevabı ve açıklamayı göster

Cevap: 10

Cevap

10

The Chi-square test of independence evaluates whether two categorical variables are associated. The null hypothesis states that the two variables (energy drink consumption and atrial fibrillation) are completely independent. If they are independent, the probability of a student having both characteristics is simply the product of their individual probabilities. The probability of consuming the drink is

200/1,000 = 0.2

. The probability of having atrial fibrillation is

50/1,000 = 0.05

. Therefore, the expected joint probability under the null hypothesis is

0.2 \times 0.05 = 0.01

. To find the expected count, this probability is multiplied by the total sample size:

0.01 \times 1,000 = 10

. Alternatively, this is calculated directly using the standard formula: Expected count =

\frac{\text{Row Total} \times \text{Column Total}}{\text{Grand Total}} = \frac{200 \times 50}{1,000} = 10

.

Adım Adım Çözüm

1

Identify the total sample size.

The total sample size (

N

) is

1,000

.

The total number of observations is required for the denominator in the expected frequency formula.

2

Identify the marginal totals for both variables of interest.

The total number of energy drink consumers (row total) is

200

. The total number of students with atrial fibrillation (column total) is

50

.

Marginal totals represent the overall frequency of each independent characteristic.

3

Apply the expected frequency formula for a Chi-square test.

Expected frequency =

\frac{200 \times 50}{1,000}

.

Under the null hypothesis of independence, the expected frequency of a cell is the product of its marginal totals divided by the grand total.

4

Calculate the final expected value.

\frac{10,000}{1,000} = 10

.

This yields the expected number of students who would have both characteristics if the variables were completely independent.

Anahtar Kavram

Calculating expected frequencies for a Chi-square test of independence.

Soru 59Soru →

A 54-year-old woman is evaluated in the intensive care unit for worsening kidney function. She was admitted four days ago for sepsis secondary to a complicated urinary tract infection and required aggressive fluid resuscitation and vasopressor support. Her urine output has steadily decreased over the past 24 hours.

Current laboratory results are as follows:
Serum sodium: 140 mEq/L
Serum creatinine: 2.1 mg/dL
Urine sodium: 60 mEq/L
Urine creatinine: 30 mg/dL

Based on these findings, what is this patient's fractional excretion of sodium (in percent)?

Cevabı ve açıklamayı göster

Cevap: 3

Cevap

3

The fractional excretion of sodium (FeNa) is 3%. The calculation is derived using the formula

FeNa = (U_{Na} \times P_{Cr}) / (P_{Na} \times U_{Cr}) \times 100

. Plugging in the values gives

(60 \times 2.1) / (140 \times 30) \times 100

, which simplifies to

126 / 4200 \times 100 = 3

. In this clinical context, a FeNa greater than 2% strongly points toward acute tubular necrosis (ATN) induced by previous ischemic shock, confirming intrinsic renal damage rather than a simple prerenal state.

Adım Adım Çözüm

1

Identify the standard formula for calculating Fractional Excretion of Sodium (FeNa).

FeNa = \frac{U_{Na} \times P_{Cr}}{P_{Na} \times U_{Cr}} \times 100

This formula relates the clearance of sodium to the clearance of creatinine to differentiate prerenal from intrinsic acute kidney injury.

2

Extract the specific laboratory values from the clinical vignette.

Urine sodium (

U_{Na}

) = 60, Plasma/Serum creatinine (

P_{Cr}

) = 2.1, Plasma/Serum sodium (

P_{Na}

) = 140, Urine creatinine (

U_{Cr}

) = 30.

These variables must be precisely assigned to avoid calculation errors.

3

Substitute the values into the formula and solve.

FeNa = \frac{60 \times 2.1}{140 \times 30} \times 100 = \frac{126}{4200} \times 100 = 0.03 \times 100 = 3

Solving the arithmetic yields the exact physiological percentage.

Anahtar Kavram

Calculation of Fractional Excretion of Sodium (FeNa)

Soru 60Soru →

A $45$ -year-old man is brought to the emergency department by his sister due to altered mental status. She states that he has a history of alcohol use disorder and was found confused in his apartment with an empty bottle of antifreeze nearby. Laboratory studies show:

Lab	Value
Serum sodium	$140 \text{ mEq/L}$
Serum potassium	$4.0 \text{ mEq/L}$
Serum chloride	$102 \text{ mEq/L}$
Serum bicarbonate	$12 \text{ mEq/L}$
Blood urea nitrogen (BUN)	$28 \text{ mg/dL}$
Serum glucose	$180 \text{ mg/dL}$
Measured serum osmolality	$325 \text{ mOsm/kg H}_2\text{O}$

Based on these laboratory results, what is this patient's calculated osmolar gap? (Provide the exact numerical value)

Cevabı ve açıklamayı göster

Cevap: 25

Cevap

The calculated osmolar gap is 25.

The patient has an elevated measured osmolality due to the ingestion of ethylene glycol (antifreeze). The calculated osmolality is

300 \text{ mOsm/kg H}_2\text{O}

, derived from the formula

2 \times \text{Na}^+ + \frac{\text{Glucose}}{18} + \frac{\text{BUN}}{2.8}

. Subtracting this calculated value from the measured osmolality of

325 \text{ mOsm/kg H}_2\text{O}

gives an osmolar gap of

25

. An elevated osmolar gap is a hallmark of toxic alcohol ingestion.

Adım Adım Çözüm

1

Calculate the estimated serum osmolality using the standard formula.

Calculated Osmolality =

2 \times 140 + \frac{180}{18} + \frac{28}{2.8} = 280 + 10 + 10 = 300 \text{ mOsm/kg H}_2\text{O}

.

The osmolar gap is the difference between measured and calculated osmolality. To find the gap, the calculated osmolality must first be determined from serum sodium, glucose, and BUN.

2

Subtract the calculated osmolality from the measured osmolality.

325 - 300 = 25

.

This yields the osmolar gap, which represents the presence of unmeasured osmotically active substances (in this case, ethylene glycol from antifreeze).

Anahtar Kavram

The osmolar gap is calculated by subtracting the calculated serum osmolality (

2 \times \text{Na}^+ + \frac{\text{Glucose}}{18} + \frac{\text{BUN}}{2.8}

) from the measured serum osmolality. An elevated osmolar gap (

>10 \text{ mOsm/kg H}_2\text{O}

) typically indicates the presence of toxic alcohols.

Tahmini Süre:1m 0s

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram